MAP4K4 and cancer: Using this analysis pipeline, we identified a novel neutrophil differentiation regulator, Mitogen-Activated Protein Kinase-4 (MAP4K4), a member of the Ste20p protein family, that has been reported to play pivotal roles in embryonic development [14,15], and cancer progression [16–18].